NICE recommends Allergan’s Ozurdex and AbbVie’s Humira for Uveitis to prevent vision loss.
National Institute for Health and Care Excellence in England and Wales are backing routine use of Allergan’s Ozurdex and AbbVie’s Humira as treatment for non-infectious posterior uveitis, which is a form of preventable vision loss. The cost regulators published their Final Appraisal Determination recommending the drugs as cost and clinically-effective treatment options for those with